Literature DB >> 2552156

The herpes simplex virus virion host shutoff function.

A D Kwong1, N Frenkel.   

Abstract

The virion host shutoff (vhs) function of herpes simplex virus (HSV) limits the expression of genes in the infected cells by destabilizing both host and viral mRNAs. vhs function mutants have been isolated which are defective in their ability to degrade host mRNA. Furthermore, the half-life of viral mRNAs is significantly longer in cells infected with the vhs-1 mutant virus than in cells infected with the wild-type (wt) virus. Recent data have shown that the vhs-1 mutation resides within the open reading frame UL41. We have analyzed the shutoff of host protein synthesis in cells infected with a mixture of the wt HSV-1 (KOS) and the vhs-1 mutant virus. The results of these experiments revealed that (i) the wt virus shutoff activity requires a threshold level of input virions per cell and (ii) the mutant vhs-1 virus protein can irreversibly block the wt virus shutoff activity. These results are consistent with a stoichiometric model in which the wt vhs protein interacts with a cellular factor which controls the half-life of cell mRNA. This wt virus interaction results in the destabilization of both host and viral mRNAs. In contrast, the mutant vhs function interacts with the cellular factor irreversibly, resulting in the increased half-life of both host and viral mRNAs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2552156      PMCID: PMC251121          DOI: 10.1128/JVI.63.11.4834-4839.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Quantitation of herpes simplex virus type 1 RNA in infected HeLa cells.

Authors:  J R Stringer; L E Holland; R I Swanstrom; K Pivo; E K Wagner
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

2.  Degradation of cellular mRNA during infection by herpes simplex virus.

Authors:  Y Nishioka; S Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

3.  The effect of herpes virus infection on mRNA in polyoma virus transformed cells.

Authors:  L I Pizer; P Beard
Journal:  Virology       Date:  1976-12       Impact factor: 3.616

4.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

5.  Properties of a supercoiled deoxyribonucleic acid-protein relaxation complex and strand specificity of the relaxation event.

Authors:  D B Clewell; D R Helinski
Journal:  Biochemistry       Date:  1970-10-27       Impact factor: 3.162

6.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

7.  Structure and expression of class II defective herpes simplex virus genomes encoding infected cell polypeptide number 8.

Authors:  H Locker; N Frenkel; I Halliburton
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

8.  Herpes simplex virus mutants defective in the virion-associated shutoff of host polypeptide synthesis and exhibiting abnormal synthesis of alpha (immediate early) viral polypeptides.

Authors:  G S Read; N Frenkel
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

9.  Early and delayed shut-off of host protein synthesis in cells infected with herpes simplex virus.

Authors:  M L Fenwick; J Clark
Journal:  J Gen Virol       Date:  1982-07       Impact factor: 3.891

10.  Inhibition of host protein synthesis and degradation of cellular mRNAs during infection by influenza and herpes simplex virus.

Authors:  S C Inglis
Journal:  Mol Cell Biol       Date:  1982-12       Impact factor: 4.272

View more
  60 in total

1.  Picornavirus internal ribosome entry site elements target RNA cleavage events induced by the herpes simplex virus virion host shutoff protein.

Authors:  M M Elgadi; J R Smiley
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Assembly of infectious Herpes simplex virus type 1 virions in the absence of full-length VP22.

Authors:  L E Pomeranz; J A Blaho
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Multimerization of ICP0, a herpes simplex virus immediate-early protein.

Authors:  J Chen; C Panagiotidis; S Silverstein
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

4.  Sequential localization of two herpes simplex virus tegument proteins to punctate nuclear dots adjacent to ICP0 domains.

Authors:  Ian Hutchinson; Alison Whiteley; Helena Browne; Gillian Elliott
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

5.  Recruitment of herpes simplex virus type 1 immediate-early protein ICP0 to the virus particle.

Authors:  Kevin Maringer; Gillian Elliott
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

6.  Entry of pseudorabies virus: an immunogold-labeling study.

Authors:  Harald Granzow; Barbara G Klupp; Thomas C Mettenleiter
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  Deletion of the herpes simplex virus VP22-encoding gene (UL49) alters the expression, localization, and virion incorporation of ICP0.

Authors:  Gillian Elliott; Wali Hafezi; Alison Whiteley; Emmanuelle Bernard
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

8.  Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis.

Authors:  L I Strelow; D A Leib
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Tristetraprolin Recruits the Herpes Simplex Virion Host Shutoff RNase to AU-Rich Elements in Stress Response mRNAs To Enable Their Cleavage.

Authors:  Minfeng Shu; Brunella Taddeo; Bernard Roizman
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

10.  Temporal regulation of herpes simplex virus type 2 VP22 expression and phosphorylation.

Authors:  B J Geiss; J E Tavis; L M Metzger; D A Leib; L A Morrison
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.